Penumbra
Builds clot-removal, embolization, and vascular-access devices for neurovascular and peripheral procedures.
$321.68
After-hours close−0.16 (−0.05%)
At close$321.84(+0.26%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 122.23%Insiders 3.34%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 39.39M · Float 38.29M · 97.2% free float
Institutions13F, as of Jun 30, 2026
474 holders · 48.14M shares · 49 new positions · 196 increased · 185 reduced · 77 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.30M | 10.91% | −32.9K | Aug 7, 2026 |
| HBK Investments L P | 1.84M | 4.67% | +204.2K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.71M | 4.34% | +15.4K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 1.67M | 4.23% | +12.8K | Aug 13, 2026 |
| State Street Corp | 1.24M | 3.16% | +57.4K | Aug 7, 2026 |
| Exoduspoint Capital Management, LP | 1.09M | 2.77% | +625.2K | Aug 14, 2026 |
| Balyasny Asset Management L.P. | 1.09M | 2.77% | +328.1K | Aug 14, 2026 |
| JPMorgan Chase & Co | 1.07M | 2.72% | +668.8K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Barclays PLC | 5.95% | 2.34M | 13G | Aug 13, 2026 ↗ |
| Vanguard Capital Management | 5.07% | 1.99M | 13G | Apr 30, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Adam Elsesser | director, officer: CEO | 865.5K | 2.20% | May 21, 2026 |
| Arani Bose | director | 259.6K | 0.66% | Feb 18, 2026 |
| Johanna Roberts | officer: EVP, Gen. Counsel & Secretary | 67.3K | 0.17% | Mar 17, 2026 |
| Lambert Shiu | officer: Chief Accounting Officer | 39.3K | 0.10% | Mar 17, 2026 |
| Shruthi Narayan | officer: President | 33.9K | 0.09% | Aug 19, 2026 |
| Maggie Yuen | officer: Chief Financial Officer | 18.2K | 0.05% | Mar 17, 2026 |
| Harpreet Grewal | director | 8.7K | 0.02% | Apr 6, 2026 |
| Janet Leeds | director | 6.6K | 0.02% | Feb 18, 2026 |
| Bridget O'Rourke | director | 6.0K | 0.02% | Feb 18, 2026 |
| Thomas Wilder | director | 5.3K | 0.01% | Feb 18, 2026 |
8 people have not refiled in the last 18 months (1.23M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 2, 2026 | Harpreet Grewaldirector | Sale | 100 | $328.22 | 8,719 |
| Mar 2, 2026 | Maggie Yuenofficer: Chief Financial Officer | Sale | 2,432 | $342.30 | 18,353 |
| Jan 6, 2026 | Harpreet Grewaldirector | Sale | 186 | $312.64 | 8,230 |
| Jan 2, 2026 | Thomas Wilderdirector | Sale | 186 | $310.72 | 0 |
| Dec 11, 2025 | Arani Bosedirector | Sale · 7 lots | 15,000 | $308.82 | 258,462 |
| Dec 5, 2025 | Johanna Robertsofficer: EVP, Gen. Counsel & Secretary | Sale | 300 | $300.13 | 63,836 |
| Dec 2, 2025 | Harpreet Grewaldirector | Sale | 100 | $292.98 | 8,416 |
| Dec 1, 2025 | Johanna Robertsofficer: EVP, Gen. Counsel & Secretary | Sale · 7 lots | 600 | $294.94 | 64,136 |
| Nov 25, 2025 | Arani Bosedirector | Sale | 7,500 | $300.19 | 275,261 |
| Nov 25, 2025 | Johanna Robertsofficer: EVP, Gen. Counsel & Secretary | Sale | 1,800 | $300.06 | 64,736 |
CongressHouse and Senate disclosures
Not reported.